AB Private Credit InvestorsTM ("AB-PCI") participated in a unitranche credit facility led by MidCap Financial to support the AGIC and Humanwell led acquisition of The Ritedose Corporation ("Ritedose"). AB-PCI leveraged its healthcare expertise to quickly deliver a meaningful commitment to the financing facility.
"As a market leader with a strong, high quality reputation, Ritedose is attractively positioned in the pharmaceutical manufacturing space to capitalize on favorable industry trends" noted Jay Ramakrishnan, Managing Director of AB-PCI. "We are excited to work with AGIC, Humanwell, MidCap and Ritedose and look forward to helping the Company continue its strong growth."
About Company: Ritedose is a leader in blow-fill-seal (BFS) manufacturing of inhalation products, eye drops, eardrops, and unit dose oral liquids on behalf of its customers and under its own label.
All rights reserved. AB Private Credit Investors is a trademark of AllianceBernstein L.P. and its affiliates. The [A/B] logo is a service mark of AllianceBernstein and AllianceBernstein® is a registered trademark used by permission of the owner, AllianceBernstein L.P.
This announcement is not a recommendation of, or offer to buy or sell any security or financial instrument.